We are live on ! Find out more
STIM icon

Neuronetics

67 hedge funds and large institutions have $31.5M invested in Neuronetics in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 25 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

2% more funds holding

Funds holding: 6667 (+1)

1.05% less ownership

Funds ownership: 59.43%58.38% (-1%)

28% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 25

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

63% less capital invested

Capital invested by funds: $84.2M → $31.5M (-$52.7M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $7K

Holders
67
Holders Change
+1
Holders Change %
+1.52%
% of All Funds
0.97%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
8
Increased
18
Reduced
25
Closed
7
Calls
Puts
$7K
Net Calls
-$7K
Net Calls Change
-$1K

STIM Hedge Fund Activity: Q2 2024 in Review

67 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q2 2024, worth a combined $31.5M — down 63% from $84.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new STIM positions and 7 closed out — a net gain of 1 holder — while 18 added to existing stakes and 25 trimmed.

The largest buyer was Kent Lake Capital, adding an estimated $2.07M. The largest seller was Divisadero Street Capital Management, cutting an estimated $4.29M.

  • 67 institutional investors held Neuronetics (STIM) as of Q2 2024, up from 66 in Q1 2024.
  • Funds reported $31.5M of Neuronetics stock for Q2 2024, down 63% quarter-over-quarter.
  • 8 funds opened new Neuronetics positions in Q2 2024 and 7 closed out, a net change of +1 holder.
  • The largest Neuronetics buyer in Q2 2024 was Kent Lake Capital, an estimated $2.07M added.
  • The largest Neuronetics seller in Q2 2024 was Divisadero Street Capital Management, an estimated $4.29M sold.

Based on aggregated 13F filings for Q2 2024.